<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2221-2450</journal-id>
<journal-title><![CDATA[Revista CENIC Ciencias Biológicas]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. CENIC Cienc. Biol]]></abbrev-journal-title>
<issn>2221-2450</issn>
<publisher>
<publisher-name><![CDATA[Centro Nacional de Investigaciones Científicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2221-24502021000100018</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Efectos protectores de la Ozonoterapia en el daño renal y hepático en la Diabetes Mellitus Tipo 2]]></article-title>
<article-title xml:lang="en"><![CDATA[Protective effects of Ozone therapy on Diabetes Mellitus type 2 renal and hepatic damage]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Calunga Fernández]]></surname>
<given-names><![CDATA[José Luis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Zamora Rodríguez]]></surname>
<given-names><![CDATA[Zullyt]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Arenas Falcón]]></surname>
<given-names><![CDATA[Benjamin]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Menéndez Cepero]]></surname>
<given-names><![CDATA[Silvia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García Hernández]]></surname>
<given-names><![CDATA[Liliana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Villena Mayeta]]></surname>
<given-names><![CDATA[Illinois]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rzepka García]]></surname>
<given-names><![CDATA[Mao]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Centro Medico De la Salud Integral México-Cuba  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Centro Nacional De Investigaciones Científicas De Cuba (CNIC)  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Consultorio Peruano Cubano (XAGYO3)  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Perú</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Colegio Mexicano de Ozonoterapia y Medicina Bio Oxidativa  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2021</year>
</pub-date>
<volume>52</volume>
<numero>1</numero>
<fpage>18</fpage>
<lpage>31</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S2221-24502021000100018&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S2221-24502021000100018&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S2221-24502021000100018&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN La Diabetes Mellitus tipo 2 cursa con grandes complicaciones graves como lo son la insuficiencia renal crónica, la hepatopatía, la neuropatía diabética y la enfermedad cerebrovascular relacionadas con una disfunción metabólica que conlleva a un estado de inflamación crónica en estos pacientes. Con el objetivo de evaluar la influencia de la ozonoterapia rectal como terapia complementaria en pacientes con diabetes Mellitus Tipo 2, se realizó un ensayo observacional en 38 pacientes con Diabetes Mellitus tipo 2. Los pacientes fueron distribuidos aleatoriamente en dos grupos, el primer grupo recibió tratamiento convencional (Metformina, Glibenclamida y vitaminas del complejo B) y ozonoterapia rectal y al segundo (Convencional) se le prescribió solamente tratamiento convencional. Se realizaron determinaciones en sangre de glicemia, hemoglobina glicosilada, LDL-colesterol, VLDL-colesterol y triglicéridos, además se les midió marcadores de daño hepático, de daño renal y la escala DNA-4 de dolor neuropático, al inicio y al finalizar las 20 sesiones de ozonoterapia rectal. El grupo de pacientes que recibió ozonoterapia rectal más el tratamiento convencional mostr&#972; disminución significativa (p( 0,05) los valores de glicemia, hemoglobina glicosilada, VLDL-colesterol, triglicérido, LDL -colesterol con respecto al grupo con tratamiento convencional. La ozonoterapia rectal, redujo significativa los marcadores de daño hepático y renal al igual que la escala de dolor DN4, con respecto al grupo que solamente recibió tratamiento convencional. La aplicación complementaria de Ozonoterapia rectal mostró un efecto protector sobre la función metabólica, hepática y renal en pacientes portadores de Diabetes Mellitus tipo 2, además mostró un cierto carácter analgésico mediante la reducción del dolor en dicha enfermedad.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Diabetes Mellitus Type 2 presents with major serious complications such as chronic kidney failure, liver disease, diabetic neuropathy, cerebrovascular disease created by metabolic dysfunction that leads to a state of chronic inflammation in these patients. With the objective of evaluating the influence of rectal ozone therapy as complementary therapy in patients with Type 2 diabetes Mellitus. 38 patients suffering Diabetes Mellitus Type 2 were selected and randomly divided into two groups. The first group (Ozone) received conventional treatment plus rectal ozone therapy and the second (Conventional) only received conventional treatment. Blood glucose, glycosylated hemoglobin, LDL-cholesterol, VLDL-cholesterol and triglycerides were measured in blood, markers of liver and kidney damage and the DNA-4 scale of neuropathic pain were measured at the beginning and at end of treatments with rectal ozone therapy. The group of patients who received rectal ozone therapy plus conventional treatment showed a significant decrease in glycemic, glycated hemoglobin, VLDL-cholesterol, triglyceride, LDL-cholesterol values &#8203;&#8203;compared to the group with conventional treatment. It reflected significant improvement in the liver and kidney damage markers as well as the levels of the DNA.-4 pain scale, compared to the group that only received conventional treatment. The complementary application of rectal ozone therapy showed a protective effect on metabolic, liver and kidney function in patients with Type 2 Diabetes Mellitus, and also showed a certain analgesic character by reducing pain in said disease.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Diabetes Mellitus tipo 2]]></kwd>
<kwd lng="es"><![CDATA[Ozonoterapia]]></kwd>
<kwd lng="es"><![CDATA[glicemia]]></kwd>
<kwd lng="es"><![CDATA[función renal]]></kwd>
<kwd lng="es"><![CDATA[función hepática]]></kwd>
<kwd lng="es"><![CDATA[dolor]]></kwd>
<kwd lng="en"><![CDATA[Diabetes Mellytus type 2]]></kwd>
<kwd lng="en"><![CDATA[Ozonetherapy]]></kwd>
<kwd lng="en"><![CDATA[glycemic]]></kwd>
<kwd lng="en"><![CDATA[renal function]]></kwd>
<kwd lng="en"><![CDATA[hepatic function]]></kwd>
<kwd lng="en"><![CDATA[pain]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Adali]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Eroglu]]></surname>
<given-names><![CDATA[H.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Makav]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Guvendi]]></surname>
<given-names><![CDATA[G.F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy of Ozone and Selenium Therapy for Alcoholic Liver Injury: An Experimental Model]]></article-title>
<source><![CDATA[In Vivo]]></source>
<year>2019</year>
<volume>33</volume>
<page-range>763-9</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ajamieh]]></surname>
<given-names><![CDATA[HH]]></given-names>
</name>
<name>
<surname><![CDATA[Berlanga]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Merino]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Carmona]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Role of protein synthesis in the protection conferred by ozone-oxidative-preconditioning in hepatic ischaemia/reperfusion]]></article-title>
<source><![CDATA[Transpl Int]]></source>
<year>2005</year>
<volume>18</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>604-12</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<collab>American Diabetes Association</collab>
<article-title xml:lang=""><![CDATA[Classification and Diagnosis of Diabetes]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2017</year>
<volume>40</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>S11-24</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bocci]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Borrelli]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Travagli]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Zanardi]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ozone Is a Strong Oxidant as Well as a Medical Drug]]></article-title>
<collab>The Ozone Paradox</collab>
<source><![CDATA[Medicinal Research Reviews]]></source>
<year>2009</year>
<volume>29</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>646-82</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calunga]]></surname>
<given-names><![CDATA[J. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Trujillo]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Menéndez]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Zamora]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Merino]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ozone oxidative postconditioning in acute renal failure]]></article-title>
<source><![CDATA[Journ. Pharma and Pharmacol]]></source>
<year>2009</year>
<volume>61</volume>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calunga]]></surname>
<given-names><![CDATA[J.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Bello]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Chaple]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Barber]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Menéndez]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Merino]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ozonoterapia en la glomerulonefritis tóxica experimental por adriamicina.]]></article-title>
<source><![CDATA[Rev Cub Invest Biomed]]></source>
<year>2004</year>
<volume>23</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>139-43</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calunga]]></surname>
<given-names><![CDATA[J.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Menéndez]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Zamora]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ozone Therapy On Rats Submitted To Subtotal Nephrectomy: Role Of Interleukin 6 And Antioxidant System]]></article-title>
<source><![CDATA[Revista Cubana de Investigaciones Biomédicas]]></source>
<year>2019</year>
<volume>38</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calunga]]></surname>
<given-names><![CDATA[J.L.F.]]></given-names>
</name>
<name>
<surname><![CDATA[Menéndez]]></surname>
<given-names><![CDATA[S.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Hutchison]]></surname>
<given-names><![CDATA[Colin Andrew]]></given-names>
</name>
</person-group>
<source><![CDATA[Protective Effects of Ozone Therapy in Renal Damage. Renal Failure Prevention, Causes and Treatment]]></source>
<year>2013</year>
<page-range>37-54</page-range><publisher-name><![CDATA[Nova Sciencie Publishers]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calunga]]></surname>
<given-names><![CDATA[J.L.F.]]></given-names>
</name>
<name>
<surname><![CDATA[Arenas]]></surname>
<given-names><![CDATA[B.F.]]></given-names>
</name>
<name>
<surname><![CDATA[León]]></surname>
<given-names><![CDATA[R.S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Presentación de un caso de pie diabético neuro-infeccioso tratado con ozonoterapia]]></article-title>
<source><![CDATA[Revista CENIC Ciencias Biológicas]]></source>
<year>2015</year>
<volume>46</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>195-202</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carrasco]]></surname>
<given-names><![CDATA[N.F.]]></given-names>
</name>
<name>
<surname><![CDATA[Galgani]]></surname>
<given-names><![CDATA[F.J.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Reyes]]></surname>
<given-names><![CDATA[J.M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome de resistencia a la insulina. Estudio y manejo]]></article-title>
<source><![CDATA[Revista Médica Clínica Las Condes]]></source>
<year>2013</year>
<volume>24</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>827-37</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cequera]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
<name>
<surname><![CDATA[García de León]]></surname>
<given-names><![CDATA[M.C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biomarcadores para fibrosis hepática, avances, ventajas y desventajas]]></article-title>
<source><![CDATA[Revista de Gastroenterología de México]]></source>
<year>2014</year>
<volume>79</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>187-99</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clavo]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Santana]]></surname>
<given-names><![CDATA[N.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Llontop]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Dominga]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Ceballo]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Mendez]]></surname>
<given-names><![CDATA[Ch.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ozone Therapy in the Management of Persistent Radiation-Induced Rectal Bleeding in Prostate Cancer Patients]]></article-title>
<source><![CDATA[Evidence Based Complementary and Alternative Medicine]]></source>
<year>2015</year>
<volume>3</volume>
<page-range>2-7</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cuevas]]></surname>
<given-names><![CDATA[A. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso]]></surname>
<given-names><![CDATA[R.K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dislipidemia Diabética]]></article-title>
<source><![CDATA[Revista Médica Clínica Las Condes]]></source>
<year>2016</year>
<volume>27</volume>
<page-range>152-9</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[L.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Riera]]></surname>
<given-names><![CDATA[R.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Mesta]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Hernandez]]></surname>
<given-names><![CDATA[M.Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Barrios]]></surname>
<given-names><![CDATA[J.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Martinez]]></surname>
<given-names><![CDATA[SG.]]></given-names>
</name>
<name>
<surname><![CDATA[Aldalaien]]></surname>
<given-names><![CDATA[S.M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medical Ozone promotes NRf2 phosphorylation reducing oxidative stress and proinflammatory cytokines in multiple sclerosis patients]]></article-title>
<source><![CDATA[European Journal of Pharmacology]]></source>
<year>2017</year>
<volume>811</volume>
<page-range>148-54</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[L.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Luna]]></surname>
<given-names><![CDATA[D.P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Productos Finales de la Glicación Avanzada en la Enfermedad Cardiovascular como complicación de la Diabetes]]></article-title>
<source><![CDATA[Revista de Medicina e Investigación]]></source>
<year>2016</year>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>52-7</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Galie]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Covi]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Tabaracci]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Malatesta]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Role of Nrf2 in the Antioxidant Cellular Response to Medical Ozone Exposure]]></article-title>
<source><![CDATA[Int. J. Mol. Sci]]></source>
<year>2019</year>
<volume>20</volume>
<page-range>40-09</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[S.J.D.]]></given-names>
</name>
<name>
<surname><![CDATA[Menéndez]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Antich]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[R.M.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Peña]]></surname>
<given-names><![CDATA[C.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Saad]]></surname>
<given-names><![CDATA[P.H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neuroprotección con Ozono en la Terapia: nuevos hallazgos en la isquemia cerebral Experimental]]></article-title>
<source><![CDATA[Revista CENIC-Ciencias Químicas]]></source>
<year>2005</year>
<volume>36</volume>
<page-range>20-30</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goicolea]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Algoritmo diagnóstico y terapéutico de la neuropatía diabética]]></article-title>
<source><![CDATA[Endocrinol Nutr]]></source>
<year>2006</year>
<volume>53</volume>
<numero>^s2</numero>
<issue>^s2</issue>
<supplement>2</supplement>
<page-range>31-3</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gutiérrez]]></surname>
<given-names><![CDATA[C.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Roura]]></surname>
<given-names><![CDATA[A.G.]]></given-names>
</name>
<name>
<surname><![CDATA[Olivares]]></surname>
<given-names><![CDATA[J.A.R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mecanismos Moleculares de la Resistencia a la Insulina: Una Actualización]]></article-title>
<source><![CDATA[Gac Med Mex]]></source>
<year>2017</year>
<volume>153</volume>
<page-range>214-28</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gutiérrez]]></surname>
<given-names><![CDATA[R.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Roura]]></surname>
<given-names><![CDATA[A.G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mecanismos Moleculares de la Resistencia a la Insulina: Una Actualización]]></article-title>
<source><![CDATA[Gac Med Mex]]></source>
<year>2017</year>
<volume>153</volume>
<page-range>214-28</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Herrero]]></surname>
<given-names><![CDATA[M.T.V.]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[S.B.]]></given-names>
</name>
<name>
<surname><![CDATA[Bandrés]]></surname>
<given-names><![CDATA[F.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez-Iñiguez de la Torre]]></surname>
<given-names><![CDATA[M.V.]]></given-names>
</name>
<name>
<surname><![CDATA[Capdevila]]></surname>
<given-names><![CDATA[L.G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Valoración del dolor. Revisión comparativa de escalas y cuestionarios]]></article-title>
<source><![CDATA[Rev Soc Esp Dolor]]></source>
<year>2018</year>
<volume>25</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>228-36</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hui]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Bianzhi]]></surname>
<given-names><![CDATA[X.]]></given-names>
</name>
<name>
<surname><![CDATA[Xiuheng]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ozone oxidative preconditioning inhibits inflammation and apoptosis in a rat model of renal ischemia/reperfusion injury]]></article-title>
<source><![CDATA[Eur J Pharmacol]]></source>
<year>2008</year>
<volume>581</volume>
<page-range>306-14</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jasso]]></surname>
<given-names><![CDATA[HLE]]></given-names>
</name>
<name>
<surname><![CDATA[Villena]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Guevara]]></surname>
<given-names><![CDATA[XL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Control metabólico en pacientes diabéticos ambulatorios de un hospital general]]></article-title>
<source><![CDATA[Rev Med Hered]]></source>
<year>2015</year>
<volume>26</volume>
<page-range>167-72</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kelley]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Jeltema]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Duan]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The NLRP3 Inflammasome: An Overview of mechanisms of Activation and Regulation]]></article-title>
<source><![CDATA[Int J .Mol Sci]]></source>
<year>2019</year>
<volume>13</volume>
</nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[León]]></surname>
<given-names><![CDATA[O.S.F.]]></given-names>
</name>
<name>
<surname><![CDATA[Viebahn]]></surname>
<given-names><![CDATA[R.H.]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[G.C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medical ozone increases methotrexate clinical response and improves cellular redox balance in patients with rheumatoid arthritis]]></article-title>
<source><![CDATA[European Journal of Pharmacology]]></source>
<year>2016</year>
<volume>789</volume>
<page-range>313-8</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Llorenç]]></surname>
<given-names><![CDATA[C.R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diabetes mellitus e hígado graso no alcohólico]]></article-title>
<source><![CDATA[Diabetes Práctica]]></source>
<year>2015</year>
<volume>6</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>49-96</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López-Heydeck]]></surname>
<given-names><![CDATA[S.M.]]></given-names>
</name>
<name>
<surname><![CDATA[López-Arriaga]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Montenegro-Morales]]></surname>
<given-names><![CDATA[L.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Cerecero]]></surname>
<given-names><![CDATA[Aguirre. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez-de Anda]]></surname>
<given-names><![CDATA[G.F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Análisis de laboratorio para el diagnóstico temprano de insuficiencia renal crónica]]></article-title>
<source><![CDATA[Rev Mex Urol]]></source>
<year>2018</year>
<volume>78</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>73-90</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Manzini]]></surname>
<given-names><![CDATA[J.L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Declaración de Helsinki: Principios éticos para la Investigación médica sobre sujetos humanos]]></article-title>
<source><![CDATA[Acta Bioethica]]></source>
<year>2000</year>
<volume>2</volume>
<page-range>321-34</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[G.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Al Dalain]]></surname>
<given-names><![CDATA[S.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Menéndez]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Re]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Giuliani]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Candelario]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Therapeutic efficacy of ozone in patients with diabetic foot]]></article-title>
<source><![CDATA[European Journal of Pharmacology]]></source>
<year>2005</year>
<volume>523</volume>
<page-range>151-61</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[G.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[L.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[A.B.]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[G.D.]]></given-names>
</name>
<name>
<surname><![CDATA[Re]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of Ozone Therapy on haemostatic and oxidative stress index in coronary artery disease]]></article-title>
<source><![CDATA[European Journal of Pharmacology]]></source>
<year>2012</year>
<volume>691</volume>
<page-range>156-62</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[G.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Mohammed]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Menéndez]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Guilliani]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[León]]></surname>
<given-names><![CDATA[O.S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ozone Treatment Reduces Blood Oxidative Stress and Pancreas Damage in a Streptozotocin-Induced Diabetes Model in Rats]]></article-title>
<source><![CDATA[Acta Farm. Bonaerense]]></source>
<year>2005</year>
<volume>24</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>491-7</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[G.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Schwartz]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Di Donna]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19]]></article-title>
<source><![CDATA[Antioxidants]]></source>
<year>2020</year>
<volume>9</volume>
<numero>389</numero>
<issue>389</issue>
<page-range>2-12</page-range></nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mata]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metformina y diabetes mellitus tipo 2]]></article-title>
<source><![CDATA[Aten Primaria]]></source>
<year>2008</year>
<volume>40</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>147-53</page-range></nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Menéndez]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Gonzalez]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Ledea]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Leon]]></surname>
<given-names><![CDATA[O.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Diaz]]></surname>
<given-names><![CDATA[M.G]]></given-names>
</name>
</person-group>
<source><![CDATA[Ozono Aspectos Básicos y aplicaciones Clínicas]]></source>
<year>2008</year>
<volume>1, 2 y 3</volume>
<edition>1era</edition>
<page-range>5-107</page-range><publisher-name><![CDATA[CNIC]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Paez]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[M.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Masmela]]></surname>
<given-names><![CDATA[K.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Parada]]></surname>
<given-names><![CDATA[Y.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Peña]]></surname>
<given-names><![CDATA[C.A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Complicaciones crónicas de la diabetes mellitus: visión práctica para el médico de atención primaria]]></article-title>
<source><![CDATA[Revista Cuarzo-Fundación Universitaria Juan N. Corpas]]></source>
<year>2016</year>
<volume>22</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>15-25</page-range></nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Peirone]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Mestre]]></surname>
<given-names><![CDATA[V.F.]]></given-names>
</name>
<name>
<surname><![CDATA[Fonseca]]></surname>
<given-names><![CDATA[M.B.]]></given-names>
</name>
<name>
<surname><![CDATA[Colaco]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Pires]]></surname>
<given-names><![CDATA[M.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Martins]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ozone therapy prevents the onset of dysplasia in HPV16-transgenic mice-A pre-clinical efficacy and safety analysis]]></article-title>
<source><![CDATA[Biomed. Pharmacother]]></source>
<year>2018</year>
<volume>104</volume>
<page-range>275-9</page-range></nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Re]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[GS]]></given-names>
</name>
<name>
<surname><![CDATA[Bordicchia]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Malcangia]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Is ozone pre-conditioning effect linked to Nrf2/EpRE activation pathway in vivo? A preliminary result]]></article-title>
<source><![CDATA[European Journal of Pharmacology]]></source>
<year>2014</year>
<volume>742</volume>
<page-range>158-62</page-range></nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reboussin]]></surname>
<given-names><![CDATA[D.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Allen]]></surname>
<given-names><![CDATA[N.B.]]></given-names>
</name>
<name>
<surname><![CDATA[Griswold]]></surname>
<given-names><![CDATA[M.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Guallar]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Hong]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Lackland]]></surname>
<given-names><![CDATA[D.T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2017</year>
<volume>1097</volume>
<numero>17</numero>
<issue>17</issue>
<page-range>41517-8</page-range></nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rios]]></surname>
<given-names><![CDATA[G.O.]]></given-names>
</name>
<name>
<surname><![CDATA[Vidal]]></surname>
<given-names><![CDATA[P.M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Manual de Prácticas para el Laboratorio de Hematología]]></article-title>
<source><![CDATA[Universidad Nacional Autónoma de México]]></source>
<year>2017</year>
<page-range>1-234</page-range></nlm-citation>
</ref>
<ref id="B40">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roche]]></surname>
<given-names><![CDATA[D.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Romo]]></surname>
<given-names><![CDATA[R.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Mesta]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Matos]]></surname>
<given-names><![CDATA[H.Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Barrios]]></surname>
<given-names><![CDATA[J.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[S.G.]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Dalain]]></surname>
<given-names><![CDATA[S.M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medical ozone promotes Nrf2 phosphorylation reducing oxidative stress and pro-inflammatory cytokines in multiple sclerosis patients]]></article-title>
<source><![CDATA[Eur. J. Pharmacol]]></source>
<year>2017</year>
<volume>811</volume>
<page-range>148-54</page-range></nlm-citation>
</ref>
<ref id="B41">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roessler]]></surname>
<given-names><![CDATA[E.B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Manejo de la Hipertensión Arterial en Diabetes Mellitus]]></article-title>
<source><![CDATA[Rev.Med.Clin.Condes]]></source>
<year>2016</year>
<volume>27</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>204-12</page-range></nlm-citation>
</ref>
<ref id="B42">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[V.C.]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[C.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Aguilar]]></surname>
<given-names><![CDATA[A.G.]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Gutiérrez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tratamiento del dolor neuropático con gabapentina en combinación con vitaminas B1 y B12. Estudio observacional prospectivo]]></article-title>
<source><![CDATA[Revista de Endocrinología y Nutrición]]></source>
<year>2012</year>
<volume>20</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>67-73</page-range></nlm-citation>
</ref>
<ref id="B43">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schwartz]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Rivera]]></surname>
<given-names><![CDATA[H.G.]]></given-names>
</name>
<name>
<surname><![CDATA[Blanche]]></surname>
<given-names><![CDATA[B.T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ozonoterapia en el tratamiento del pie diabético neuroinfeccioso. Reporte de caso]]></article-title>
<source><![CDATA[Ozone Therapy Global Journal]]></source>
<year>2019</year>
<volume>9</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>125-33</page-range></nlm-citation>
</ref>
<ref id="B44">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Takayanagi]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Inoguchi]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Ohnaka]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical and experimental evidence for oxidative stress as an exacerbating factor of diabetes mellitus]]></article-title>
<source><![CDATA[J Clin Biochem Nutr]]></source>
<year>2011</year>
<volume>48</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>72-7</page-range></nlm-citation>
</ref>
<ref id="B45">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[X.]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Fu]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Low-Concentration Oxygen/Ozone Treatment Attenuated Radiculitis and Mechanical Allodynia via PDE2A-cAMP/cGMP-NF-&#954;B/p65 Signaling in Chronic Radiculitis Rats]]></article-title>
<source><![CDATA[Pain Res. Manag]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B46">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Meng]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ozone protects the rat lung from ischemia-reperfusion injury by attenuating NLRP3-mediated inflammation, enhancing Nrf2 antioxidant activity and inhibiting apoptosis]]></article-title>
<source><![CDATA[European Journal of Pharmacology]]></source>
<year>2018</year>
<volume>835</volume>
<page-range>82-93</page-range></nlm-citation>
</ref>
<ref id="B47">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zamora]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Borrego]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Orlay]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of ozone oxidative preconditioning on TNF alfa release and antioxidant prooxidant intracellular balance in mice during endotoxic shock]]></article-title>
<source><![CDATA[Mediat Inflamm]]></source>
<year>2005</year>
<volume>1</volume>
<page-range>16-22</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
